T-E Pharma announced that its subsidiary, T-E Meds, Inc., has been shortlisted for the prestigious “Best New Drug Developer” category at the 12th World ADC Awards 2025. Selected from a highly competitive pool of global nominees, T-E Meds is one of six finalists. The winners—Champion and Runner-up—will be revealed on November 5, 2025 (Wednesday) at … Continue reading T-E Meds Shortlisted for World ADC Awards, Showcasing Global Recognition of Its Innovative Platform and Pipeline